Skip to main content

Table 7 Summary of plasma I2S activity and urinary GAGs concentration at baseline according to phenotype and age at diagnosis

From: A review of the clinical outcomes in idursulfase-treated and untreated Filipino patients with mucopolysaccharidosis type II: data from the local lysosomal storage disease registry

 

Plasma enzyme assay level (nmol/mg plasma/4 h)

Plasma enzyme assay level (uM/hr)

Urinary GAG concentration (mg/mg creatinine)

HS ng/ug Crea

DS ng/ug Crea

According to phenotype

Attenuated (n = 8)

M (SD) range

0.37

(0.31) 0.01–0.91

NA

465.73

(211) 145.35–692.59

NA

NA

Severe (n = 32)

M (SD) range

0.58

(0.62) 0.01–2.34

0.124

(0.031) 0.09–0.17

547.04

(210.98) 126.1–911.46

35.87

(17.15) 14.85–58.4

21.22

(15.38) 4.33–45.8

 

Plasma enzyme assay level (nmol/mg plasma/4 h)

Plasma enzyme assay level (> 4.45 uM/hr)

Urinary GAG concentration (mg/mg creatinine)

HS ng/ug Crea

DS ng/ug Crea

According to age at diagnosis

 < 6 years (n = 15)

0.50

(0.59) 0.01–1.96

0.1

(0.01) 0.09–0.11

548.72

(232.12) 238.09–911.45

52.12

(6.92) 42.28–58.4

17.51

(11.74) 4.33–31.67

6–10 years (n = 20)

0.55

(0.59) 0.01–2.34

0.11

N/A

494.72

(205.92) 126.1–778.62

20.48

(0.45) 20.16–20.8

26.8

(26.87) 7.8–45.8

 > 10 years (n = 5)

0.39

(0.52) 0.04–1.15

NA

549.65

NA

21.19

(8.96) 14.85–27.53

18.12

(19.30) 4.47–31.76